Meanwhile, ETV4 could recruit LOXL2 to the promoter region of NID1 for mediating demethylation and expression of NID1, which in turn activated the ERK pathway to promote cell proliferation, EMT and metastasis in CRC. Here, LOXL2 is linked to colorectal carcinoma.